Skip to main content
. 2020 Nov 17;21(22):8653. doi: 10.3390/ijms21228653
AD Alzheimer’s disease
Akt Protein kinase B
AP-1 Activator protein 1
Amyloid beta peptide
BBB Blood–brain barrier
C3G Cyanidin-3-O-glucoside
CNS Central nervous system
COX-2 Cyclooxygenase-2
DG D-galactose
ERK Extracellular signal-regulated kinase
GA Gallic acid
HBA 4-hydroxybenzoic acid
IFN Interferon
IKK IκB kinase
IL Interleukin
iNOS Nitric oxide synthase
JAK Janus kinase
JNK c-jun N-terminal kinase
LPS Lipopolysaccharide
MAPK Mitogen-activated protein kinase
MLK3 Mixed-lineage protein kinase 3
MS Multiple sclerosis
mTOR Mammalian target of rapamycin
NF-κB Nuclear factor kappa B
NLRP3 NLR family pyrin domain-containing protein 3
NO Nitric oxide
PA Protocatechuic acid
PD Parkinson’s disease
PGE2 Prostaglandin E2
PI3K Phosphoinositide 3-kinase
PND Perioperative neurocognitive disorder
ROS Reactive oxygen species
STAT Signal transducer and activator of transcription
TLR Toll-like receptor
TNF Tumor necrosis factor
VA Vanillic acid